Drug intelligence / Profile preview

betamethasone valerate + salicylic acid

Development stage
Unknown
Lead developer
Deurali Janta Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Beta-S is a topical combination ointment containing betamethasone valerate (0.1% w/w) and salicylic acid (3% w/w). Developed by Deurali Janta Pharmaceuticals, it is indicated for the treatment of inflammatory and keratotic skin conditions, such as psoriasis, eczema, and dermatitis. Betamethasone valerate is a potent topical corticosteroid that reduces inflammation, redness, and itching by acting as a glucocorticoid receptor agonist. Salicylic acid is a keratolytic agent that softens and exfoliates the outer layer of the skin, which facilitates the penetration and absorption of the corticosteroid into the affected skin layers.

Brand names
Beta-SBetnovate-SDawasalic
Other names
betamethasone valerate + salicylic acidbetamethasone valerate and salicylic acidbetamethasone valerate/salicylic acidsalicylic acid + betamethasone valeratesalicylic acid and betamethasone valeratesalicylic acid/betamethasone valerate
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on betamethasone valerate + salicylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone valerate + salicylic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call